About me
Melanie Marota is a director at Merck and has over 15 years of experience in oral drug product development. She has made substantial contributions to Merck’s pipeline culminating in multiple commercial products including Belsomra, Zepatier, Welireg, and Lagevrio. Melanie has successfully led the formulation or project teams on pipeline assets spanning Merck’s HCV portfolio, CoV programs, and oral peptide delivery. Her experience in enabled formulation development includes spray drying, downstream processing, and commercial scale-up. She has authored and contributed to numerous publications, presentations, and patent applications.
